UniClose

Innovative Class III Medical Device · Pioneering a Universal Port Closure Ecosystem

Based on the clinical application scenarios of TroClose 1200^TM 2.0, Lujian Technology has promoted the R&D of UniClose, an innovative puncture-suturing device designed to adapt to more diverse surgical scenarios and robotic systems.

1. Product Introduction

UniClose (Laparoscopic Universal Closure Device) is a leading Class III innovative medical device globally, pioneering the full-layer closure technique. It achieves the clinical goals of “single deployment, automatic closure, and zero hernia.” Additionally, UniClose is compatible with any mainstream surgical trocar, independent of the specific manufacturer, further promoting the widespread adoption of automatic suturing technology in laparoscopic procedures. UniClose significantly enhances surgical safety, shortens operation time, optimizes intraoperative trauma control, and improves patient outcomes. This technique adapts to patients of various body types and surgical approaches, reducing the risk of postoperative infection, with easy operation, a short learning curve, and outstanding clinical application value.

Product Technology Architecture:

Integrated Design: The universal anchor and degradable implant components are deeply integrated, simplifying the surgical process with an "inside-out" suturing logic, ensuring full-standard closure of the trocar cannula.

Full Compatibility: The patented neck component seamlessly fits all 10-15mm trocar cannulas (including Da Vinci robot ports) without changing instruments, providing plug-and-play functionality.

One-Touch Precise Deployment: The ergonomic grip deploys the PLGA absorbable suture anchor with precise 90-degree insertion into the fascial layer, simplifying the process and ensuring accurate placement.

Efficient Zero-Gap Closure: The suture tail automatically tightens, and the half-loop knot technique reduces incision tension by 75%, achieving quick, tight tissue approximation.

Robotic-Specific Solution: Optimized for the Da Vinci platform, the mechanical lock ensures stable movement, submillimeter precision matching with fine scale, and high-contrast coloring visible in the 3D view, solving the challenge of robotic surgical port closure.

2. Market Outlook

With the continuous increase in minimally invasive surgery adoption, the laparoscopic and robot-assisted surgery markets are maintaining growth, and the demand for innovative devices in incision management and postoperative complication control is expanding. This is expected to create a multi-billion-dollar market space.

Surgical Volume: In 2024, the total number of laparoscopic surgeries in China is expected to reach 9.7 million, with projections surpassing 12 million by 2027, representing a compound annual growth rate (CAGR) of 17.5%.

Consumables Demand: The annual sales of single-use trocars have exceeded 28.5 million units. The versatility of UniClose allows it to cover all closure needs after trocar use, with potential market space corresponding 1:1 to the trocar market.

Robotics Growth: The surgical robot market is growing at an annual rate of 15%, and the demand for closure devices compatible with robotic ports is increasing exponentially.